Feasibility of a Virtually Supported Home-Based Resistance and Aerobic Exercise Program for Cancer Survivors With Multiple Myeloma
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 31
- 试验地点
- 2
- 主要终点
- Feasibility (Adherence)
研究概览
简要总结
The primary objective of this pilot study is to determine the safety and feasibility a 12-week virtually supported home-based aerobic and resistance exercise program progressing cancer survivors with Multiple Myeloma to meet standards identified in the 2019 Exercise Guidelines for Cancer Survivors.
The protocol will be measuring recruitment, adherence, completion, cost tracking, as well as fitness and quality of life outcomes. The study will be a single-group prospective before and after study that will help inform a future larger-scale project. We will aim to recruit 25 participants.
The Health Research Ethics Board of Alberta Cancer Committee will approve this study. Participants will participate in a combined resistance and aerobic exercise program biweekly for 12 weeks. Exercise sessions will be supported and progressive in nature, between 40 and 75 minutes each.
Analyses: fitness testing and quality of life scales will be administered before and after the intervention. Scores will be compared to evaluate changes over the course of the intervention. Safety and feasibility information will be collected throughout the study and evaluated to determine program feasibility. Program satisfaction will be evaluated using a satisfaction survey.
详细描述
Multiple myeloma (MM), a cancer of the plasma cells in bone marrow, is associated with osteolytic bone destruction, leading to deformities, chronic pain, reduced mobility and functioning, fatigue, and risk of fracture. Although incurable, newly developed therapies are extending survival, but some with significant side-effects. Patients may be living longer but with lasting, debilitating side-effects.
Exercise has been proposed as a way to optimize patient function and quality of life in the face of lasting symptom burden. However, current evidence-informed exercise guidelines for cancer survivors may not be appropriate for those with bone fragility, including those with MM, as they are based on findings from studies in breast and prostate cancers. In MM specifically, the literature presents mixed results, and several studies have limited generalizability, reproducibility, or were underdosed.
The main objective of this study is to determine the safety and feasibility of a 12-week virtually supported home-based aerobic and resistance exercise program that aims to progress individuals to the 2019 Exercise Guidelines for Cancer Survivors in a sample of cancer survivors with multiple myeloma, as defined by:
- Recruitment rate: ≥ 21 participants consenting to the study over a 7-month recruitment period (primary endpoint)
- Completion rate: ≥ 80% of participants consenting to the study complete the 12-week assessment
- Safety: no increase in the rate of bony events above those estimated to occur in the target population
- Adherence: average completion of ≥ 75% of the exercise prescription amongst participants
We will aim to recruit 25 participants from clinics at the local cancer hospital, the local disease-group support society, and from the currently accruing Alberta Cancer Exercise program. Subjects will be screened for eligibility and if they meet all eligibility criteria, an information letter of the study will be provided, and they will be asked to contact the investigators if interested in taking part in the study. All participants will be required to provide written informed consent as per the Health Research Ethics Board of Alberta: Cancer Committee (HREBA).
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 years of age and older
- •Diagnosis of multiple myeloma
- •In one of the following three treatment categories:
- •Transplant ineligible patients, currently in first line treatment
- •Transplant eligible patients, sufficiently recovered from transplantation (>3 months following transplantation)
- •Patients with relapsed/recurrent myeloma with either 1-3 prior lines of treatment or 4+ prior lines
- •Able to provide informed written consent in English
- •Approved for physical activity participation by their oncologist and cleared for physical activity by the Certified Exercise Physiologist on the PAR-Q+
排除标准
- •Unstable cardiac/metabolic condition that would be deemed unsafe to exercise
- •Severe anemia
- •Spinal instability requiring surgical intervention
- •AL amyloidosis, solitary plasmacytoma, or Waldenstrom macroglobulinemia
- •Too frail to participate in home exercise, as determine by baseline physical assessment (i.e., unable to complete a single sit-to-stand or balance on one foot for ≥ 3 seconds).
- •Inability to provide consent
- •Inability to commit to, and/or comply with the intervention due to personal reasons (e.g. vacation planned during the intervention period)
结局指标
主要结局
Feasibility (Adherence)
时间窗: 12 weeks
The percentage of total exercise dose prescribed that was actually completed (%)
次要结局
- Feasibility (Recruitment rate)(7 months)
- Feasibility (Completion rate)(12 weeks)
- Feasibility (Safety)(12 weeks)